Immunocytes in the tumor microenvironment: recent updates and interconnections

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• The tumor microenvironment (TME) is a complex ecosystem of tumor cells, immune cells, and stromal cells.
• The TME evolves over time, transitioning from an initial pro-inflammatory state to a later immunosuppressive one.
• Key immune cells within the TME exhibit plasticity, influencing tumor growth and metastasis.

Purpose of the Study:

• To review the evolving composition and function of the tumor microenvironment.
• To highlight the dual roles of immunocytes in tumor progression.
• To discuss emerging therapeutic strategies targeting the TME.

Main Methods:

• Literature review of the tumor microenvironment.
• Analysis of immunocyte roles and plasticity within the TME.
• Overview of current and emerging cancer immunotherapies.

Main Results:

• The TME transitions from immune-promoting to immunosuppressive via metabolic reprogramming and hypoxia.
• Immunocytes like T cells, NK cells, macrophages, and MDSCs have context-dependent roles.
• Immune cell plasticity, such as macrophage polarization and T cell balance, significantly impacts tumor outcomes.
• Emerging therapies like checkpoint inhibitors and CAR T/NK cells show promise.

Conclusions:

• Deciphering the interplay between immunocytes and the TME is crucial for effective cancer immunotherapy.
• Targeting metabolic pathways and immune cell plasticity offers new therapeutic avenues.
• Further research into TME dynamics will drive advancements in cancer treatment.